tiprankstipranks
Trending News
More News >
UnitedHealth (UNH)
NYSE:UNH
US Market

UnitedHealth (UNH) Ratios

Compare
12,479 Followers

UnitedHealth Ratios

UNH's free cash flow for Q4 2024 was $0.21. For the 2024 fiscal year, UNH's free cash flow was decreased by $ and operating cash flow was $0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.83 0.79 0.77 0.79 0.74
Quick Ratio
0.83 0.79 0.77 0.79 0.74
Cash Ratio
0.24 0.26 0.26 0.27 0.23
Solvency Ratio
0.09 0.15 0.15 0.15 0.14
Operating Cash Flow Ratio
0.23 0.29 0.29 0.29 0.31
Short-Term Operating Cash Flow Coverage
5.33 6.80 8.43 6.17 4.60
Net Current Asset Value
$ -109.91B$ -96.36B$ -90.29B$ -73.97B$ -73.03B
Leverage Ratios
Debt-to-Assets Ratio
0.26 0.23 0.23 0.22 0.22
Debt-to-Equity Ratio
0.83 0.70 0.74 0.64 0.66
Debt-to-Capital Ratio
0.45 0.41 0.43 0.39 0.40
Long-Term Debt-to-Capital Ratio
0.44 0.40 0.41 0.37 0.37
Financial Leverage Ratio
3.22 3.08 3.16 2.96 3.01
Debt Service Coverage Ratio
7.73 3.53 5.02 4.26 3.14
Interest Coverage Ratio
-8.27 9.97 13.59 14.44 13.47
Debt to Market Cap
0.16 0.13 0.12 0.10 0.13
Interest Debt Per Share
78.58 70.89 63.93 50.54 47.71
Net Debt to EBITDA
5.28 1.14 1.08 0.91 1.05
Profitability Margins
Gross Profit Margin
22.33%23.64%24.09%23.60%25.62%
EBIT Margin
4.04%7.77%0.00%0.00%0.00%
EBITDA Margin
2.44%8.85%9.88%9.49%9.90%
Operating Profit Margin
8.07%8.80%8.83%8.40%8.76%
Pretax Profit Margin
5.01%7.92%8.18%7.82%8.11%
Net Profit Margin
3.60%6.09%6.25%6.06%6.03%
Continuous Operations Profit Margin
3.81%6.30%6.41%6.22%6.17%
Net Income Per EBT
71.77%76.88%76.38%77.48%74.26%
EBT Per EBIT
62.16%89.97%92.64%93.07%92.58%
Return on Assets (ROA)
4.83%8.18%8.19%8.15%7.81%
Return on Equity (ROE)
15.55%25.22%25.87%24.09%23.52%
Return on Capital Employed (ROCE)
16.60%18.53%18.17%17.90%17.94%
Return on Invested Capital (ROIC)
12.32%14.38%13.96%13.85%13.13%
Return on Tangible Assets
8.56%14.46%14.58%13.68%13.38%
Earnings Yield
3.07%4.58%4.06%3.65%4.64%
Efficiency Ratios
Receivables Turnover
8.26 9.43 10.58 10.16 10.06
Payables Turnover
4.53 8.78 4.31 4.44 4.29
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
37.93 32.10 31.81 31.81 29.64
Asset Turnover
1.34 1.34 1.31 1.34 1.30
Working Capital Turnover Ratio
-20.74 -18.02 -17.55 -16.19 -13.51
Cash Conversion Cycle
-36.31 -2.86 -50.23 -46.34 -48.90
Days of Sales Outstanding
44.18 38.70 34.50 35.93 36.27
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
80.50 41.56 84.73 82.27 85.17
Operating Cycle
44.18 38.70 34.50 35.93 36.27
Cash Flow Ratios
Operating Cash Flow Per Share
26.05 31.32 28.06 23.69 23.44
Free Cash Flow Per Share
22.29 27.67 25.06 21.09 21.27
CapEx Per Share
3.77 3.65 3.00 2.60 2.17
Free Cash Flow to Operating Cash Flow
0.86 0.88 0.89 0.89 0.91
Dividend Paid and CapEx Coverage Ratio
2.19 2.86 2.98 2.89 3.34
Capital Expenditure Coverage Ratio
6.92 8.58 9.35 9.10 10.81
Operating Cash Flow Coverage Ratio
0.31 0.46 0.45 0.49 0.51
Operating Cash Flow to Sales Ratio
0.06 0.08 0.08 0.08 0.09
Free Cash Flow Yield
4.41%5.26%4.73%4.20%6.07%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
32.62 21.83 24.61 27.39 21.54
Price-to-Sales (P/S) Ratio
1.17 1.33 1.54 1.66 1.30
Price-to-Book (P/B) Ratio
5.07 5.50 6.37 6.60 5.07
Price-to-Free Cash Flow (P/FCF) Ratio
22.70 19.02 21.16 23.81 16.49
Price-to-Operating Cash Flow Ratio
19.42 16.81 18.90 21.19 14.96
Price-to-Earnings Growth (PEG) Ratio
-0.91 1.82 1.41 2.18 1.81
Price-to-Fair Value
5.07 5.50 6.37 6.60 5.07
Enterprise Value Multiple
53.39 16.17 16.63 18.40 14.16
EV to EBITDA
53.39 16.17 16.63 18.40 14.16
EV to Sales
1.30 1.43 1.64 1.75 1.40
EV to Free Cash Flow
25.19 20.47 22.62 25.05 17.80
EV to Operating Cash Flow
21.55 18.08 20.20 22.30 16.16
Tangible Book Value Per Share
-29.51 -21.56 -22.92 -9.93 -12.32
Shareholders’ Equity Per Share
99.74 95.64 83.27 76.10 69.23
Tax and Other Ratios
Effective Tax Rate
0.24 0.21 0.22 0.21 0.24
Revenue Per Share
430.87 396.05 344.90 302.52 270.23
Net Income Per Share
15.51 24.12 21.54 18.33 16.28
Tax Burden
0.72 0.77 0.76 0.77 0.74
Interest Burden
1.24 1.02 0.00 0.00 0.00
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.59 1.30 1.27 1.26 1.41
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis